Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment EP News Bureau Apr 16, 2025 Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Antag Therapeutics secures €80 million Series A financing EP News Bureau Dec 5, 2024 Funds to advance AT-7687 and expand obesity treatment pipeline
